ETopical – Lifestyle
Home
Sample Page
Author:
Immusoft
Immusoft to Present Data Highlighting Positive Results from the World’s First Engineered B Cell in a Human Clinical Trial at ASGCT 2026
May 6, 2026
Immusoft Announces Presentation of World’s First Patient Treated with an Engineered B Cell Therapy at Workshop Co-Hosted by FDA and ARM
April 8, 2026
Immusoft Awarded $15 Million in Funding from the California Institute for Regenerative Medicine
March 30, 2026